{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:50:26Z","timestamp":1788191426314,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s12028-024-01941-3","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T13:02:07Z","timestamp":1708434127000},"page":"202-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety and Effect on Intracranial Pressure of 3% Hypertonic Saline Bolus Via Peripheral Intravenous Catheter for Neurological Emergencies"],"prefix":"10.1007","volume":"41","author":[{"given":"Farid","family":"Khasiyev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Hakoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0901-341X","authenticated-orcid":false,"given":"Fajun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"issue":"3","key":"1941_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12028-020-00959-7","volume":"32","author":"AM Cook","year":"2020","unstructured":"Cook AM, Morgan Jones G, Hawryluk GWJ, et al. Guidelines for the acute treatment of cerebral edema in neurocritical care patients. Neurocrit Care. 2020;32(3):647\u201366. https:\/\/doi.org\/10.1007\/s12028-020-00959-7.","journal-title":"Neurocrit Care"},{"issue":"1","key":"1941_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C, et al. Guidelines for the management of severe traumatic brain injury. Neurosurgery. 2017;80(1):6\u201315. https:\/\/doi.org\/10.1227\/NEU.0000000000001432.","journal-title":"Neurosurgery"},{"issue":"12","key":"1941_CR3","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s00134-019-05805-9","volume":"45","author":"GWJ Hawryluk","year":"2019","unstructured":"Hawryluk GWJ, Aguilera S, Buki A, et al. A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC). Intensive Care Med. 2019;45(12):1783\u201394. https:\/\/doi.org\/10.1007\/s00134-019-05805-9.","journal-title":"Intensive Care Med"},{"issue":"7","key":"1941_CR4","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1161\/STR.0000000000000436","volume":"54","author":"BL Hoh","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, et al. 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2023;54(7):e314\u201370. https:\/\/doi.org\/10.1161\/STR.0000000000000436.","journal-title":"Stroke"},{"issue":"2","key":"1941_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12028-022-01604-1","volume":"38","author":"SK O\u2019Brien","year":"2023","unstructured":"O\u2019Brien SK, Koehl JL, Demers LB, Hayes BD, Barra ME. Safety and tolerability of 23.4% hypertonic saline administered over 2 to 5 minutes for the treatment of cerebral herniation and intracranial pressure elevation. Neurocrit Care. 2023;38(2):312\u20139. https:\/\/doi.org\/10.1007\/s12028-022-01604-1.","journal-title":"Neurocrit Care"},{"issue":"9","key":"1941_CR6","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1365-2044.2009.05986.x","volume":"64","author":"GF Strandvik","year":"2009","unstructured":"Strandvik GF. Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure. Anaesthesia. 2009;64(9):990\u20131003. https:\/\/doi.org\/10.1111\/j.1365-2044.2009.05986.x.","journal-title":"Anaesthesia"},{"issue":"35","key":"1941_CR7","doi-asserted-by":"publisher","first-page":"e21655","DOI":"10.1097\/MD.0000000000021655","volume":"99","author":"J Shi","year":"2020","unstructured":"Shi J, Tan L, Ye J, Hu L. Hypertonic saline and mannitol in patients with traumatic brain injury: a systematic and meta-analysis. Medicine. 2020;99(35):e21655.","journal-title":"Medicine"},{"key":"1941_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12028-011-9649-x","volume":"17","author":"A Torre-Healy","year":"2012","unstructured":"Torre-Healy A, Marko NF, Weil RJ. Hyperosmolar therapy for intracranial hypertension. Neurocrit Care. 2012;17:117\u201330.","journal-title":"Neurocrit Care"},{"issue":"20","key":"1941_CR9","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1001\/jama.2021.5561","volume":"325","author":"A Roquilly","year":"2021","unstructured":"Roquilly A, Moyer JD, Huet O, et al. Effect of continuous infusion of hypertonic saline vs standard care on 6-month neurological outcomes in patients with traumatic brain injury: the COBI randomized clinical trial. JAMA. 2021;325(20):2056\u201366.","journal-title":"JAMA"},{"issue":"6","key":"1941_CR10","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/00003246-199806000-00038","volume":"26","author":"JI Suarez","year":"1998","unstructured":"Suarez JI, Qureshi AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med. 1998;26(6):1118\u201322.","journal-title":"Crit Care Med"},{"issue":"13","key":"1941_CR11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1212\/01.wnl.0000304042.05557.60","volume":"70","author":"M Koenig","year":"2008","unstructured":"Koenig M, Bryan M, Lewin J 3rd, Mirski MA, Geocadin R, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70(13):1023\u20139.","journal-title":"Neurology"},{"issue":"1","key":"1941_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/hs0102.100877","volume":"33","author":"S Schwarz","year":"2002","unstructured":"Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33(1):136\u201340.","journal-title":"Stroke"},{"issue":"4","key":"1941_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1227\/01.NEU.0000175726.08903.0A","volume":"57","author":"ML Ware","year":"2005","unstructured":"Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley GT. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery. 2005;57(4):727\u201336.","journal-title":"Neurosurgery"},{"issue":"6","key":"1941_CR14","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1227\/01.NEU.0000359533.16214.04","volume":"65","author":"GL Rockswold","year":"2009","unstructured":"Rockswold GL, Solid CA, Paredes-Andrade E, Rockswold SB, Jancik JT, Quickel RR. Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen. Neurosurgery. 2009;65(6):1035\u201342.","journal-title":"Neurosurgery"},{"issue":"3","key":"1941_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1177\/0148607114521833","volume":"38","author":"JI Boullata","year":"2014","unstructured":"Boullata JI, Gilbert K, Sacks G, et al. ASPEN clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing. J Parenter Enter Nutr. 2014;38(3):334\u201377.","journal-title":"J Parenter Enter Nutr"},{"key":"1941_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ajem.2023.04.007","volume":"69","author":"CS Brown","year":"2023","unstructured":"Brown CS, Rabinstein AA, Zhao Y, Wieruszewski ED. Safety of peripheral 3% hypertonic saline bolus administration for neurologic emergency. Am J Emerg Med. 2023;69:83\u20136. https:\/\/doi.org\/10.1016\/j.ajem.2023.04.007.","journal-title":"Am J Emerg Med"},{"issue":"3","key":"1941_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/JNN.0000000000000286","volume":"49","author":"CA Perez","year":"2017","unstructured":"Perez CA, Figueroa SA. Complication rates of 3% hypertonic saline infusion through peripheral intravenous access. J Neurosci Nurs. 2017;49(3):191\u20135. https:\/\/doi.org\/10.1097\/JNN.0000000000000286.","journal-title":"J Neurosci Nurs"},{"issue":"1","key":"1941_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4037\/ajcc2017439","volume":"26","author":"GM Jones","year":"2017","unstructured":"Jones GM, Bode L, Riha H, Erdman MJ. Safety of continuous peripheral infusion of 3% sodium chloride solution in neurocritical care patients. Am J Crit Care. 2017;26(1):37\u201342.","journal-title":"Am J Crit Care"},{"issue":"1","key":"1941_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0885066617702590","volume":"33","author":"RC Dillon","year":"2018","unstructured":"Dillon RC, Merchan C, Altshuler D, Papadopoulos J. Incidence of adverse events during peripheral administration of sodium chloride 3%. J Intensive Care Med. 2018;33(1):48\u201353. https:\/\/doi.org\/10.1177\/0885066617702590.","journal-title":"J Intensive Care Med"},{"key":"1941_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fmed.2019.00047","volume":"6","author":"JC Ayus","year":"2019","unstructured":"Ayus JC, Moritz ML. Misconceptions and barriers to the use of hypertonic saline to treat hyponatremic encephalopathy. Front Med. 2019;6:47.","journal-title":"Front Med"},{"issue":"4","key":"1941_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jemermed.2018.12.046","volume":"56","author":"E Mesghali","year":"2019","unstructured":"Mesghali E, Fitter S, Bahjri K, Moussavi K. Safety of peripheral line administration of 3% hypertonic saline and mannitol in the emergency department. J Emerg Med. 2019;56(4):431\u20136. https:\/\/doi.org\/10.1016\/j.jemermed.2018.12.046.","journal-title":"J Emerg Med"},{"issue":"2","key":"1941_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.amjms.2023.04.025","volume":"366","author":"J Madieh","year":"2023","unstructured":"Madieh J, Hasan B, Khamayseh I, et al. The safety of intravenous peripheral administration of 3% hypertonic saline: a systematic review and meta-analysis. Am J Med Sci. 2023;366(2):135\u201342. https:\/\/doi.org\/10.1016\/j.amjms.2023.04.025.","journal-title":"Am J Med Sci"},{"issue":"9596","key":"1941_CR23","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"issue":"3","key":"1941_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s12028-021-01248-7","volume":"35","author":"L Faiver","year":"2021","unstructured":"Faiver L, Hensler D, Rush SC, Kashlan O, Williamson CA, Rajajee V. Safety and efficacy of 23.4% sodium chloride administered via peripheral venous access for the treatment of cerebral herniation and intracranial pressure elevation. Neurocrit Care. 2021;35(3):845\u201352. https:\/\/doi.org\/10.1007\/s12028-021-01248-7.","journal-title":"Neurocrit Care"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-024-01941-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-024-01941-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-024-01941-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T08:52:15Z","timestamp":1724748735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-024-01941-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1941"],"URL":"https:\/\/doi.org\/10.1007\/s12028-024-01941-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3346339\/v1","asserted-by":"object"}]},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"11 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This study was approved by Saint Louis University Institutional Review Board, and informed consent was waived given the nature of the retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}}]}}